Predictions
Evoke Pharma Inc.
Start price
Target price
Perf. (%)
€32.66
18.11.20
18.11.20
€60.00
18.11.21
18.11.21
-3.60%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.66
18.11.20
18.11.20
€1.00
18.11.21
18.11.21
25.80%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Arca Biopharma
Start price
Target price
Perf. (%)
€3.36
18.11.20
18.11.20
€5.00
18.11.21
18.11.21
5.36%
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€2.39
18.11.20
18.11.20
€4.00
30.50%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.00
18.11.20
18.11.20
€82.00
18.11.21
18.11.21
-10.59%
12.09.21
12.09.21
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€6.21
18.11.20
18.11.20
€5.00
-7.09%
30.11.20
30.11.20
Risky Investment
MagForce AG
Start price
Target price
Perf. (%)
€3.01
18.11.20
18.11.20
€4.00
18.11.21
18.11.21
12.29%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Sunwin Stevia Intl.
Start price
Target price
Perf. (%)
€0.055
17.11.20
17.11.20
€0.000
17.11.21
17.11.21
-41.82%
18.11.21
18.11.21
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.55
16.11.20
16.11.20
€105.00
16.11.21
16.11.21
-10.40%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.16
16.11.20
16.11.20
-
16.11.21
16.11.21
15.87%
03.02.21
03.02.21
Aptevo Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.20
16.11.20
16.11.20
-
16.11.21
16.11.21
-77.34%
17.11.21
17.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Alterity Therapeutics Ltd. ADR
Start price
Target price
Perf. (%)
€25.50
16.11.20
16.11.20
-
16.11.21
16.11.21
-60.78%
17.11.21
17.11.21
Probably not worthwhile Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.45
16.11.20
16.11.20
-
16.11.21
16.11.21
-14.81%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Nanorepro AG
Start price
Target price
Perf. (%)
€3.36
16.11.20
16.11.20
-
16.11.21
16.11.21
0.60%
26.11.20
26.11.20
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€7.30
15.11.20
15.11.20
€8.00
-4.11%
29.11.20
29.11.20
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€24.62
15.11.20
15.11.20
€25.00
-3.98%
29.11.20
29.11.20
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.10
15.11.20
15.11.20
€5.50
15.11.21
15.11.21
7.86%
16.11.21
16.11.21
Could be worthwhile Investment >10% per year
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.54
15.11.20
15.11.20
-
15.11.21
15.11.21
-29.53%
16.11.21
16.11.21